{"id":91035,"date":"2019-05-20T23:03:24","date_gmt":"2019-05-21T06:03:24","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2019\/05\/new-single-vaccination-approach-to-killer-diseases"},"modified":"2019-05-20T23:03:24","modified_gmt":"2019-05-21T06:03:24","slug":"new-single-vaccination-approach-to-killer-diseases","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2019\/05\/new-single-vaccination-approach-to-killer-diseases","title":{"rendered":"New single vaccination approach to killer diseases"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/new-single-vaccination-approach-to-killer-diseases2.jpg\"><\/a><\/p>\n<p>Scientists from the University of Adelaide\u2019s Research Centre for Infectious Diseases have developed a single vaccination approach to simultaneously combat influenza and pneumococcal infections, the world\u2019s most deadly respiratory diseases.<\/p>\n<p>The researchers say a single vaccination\u2014combining vaccines from the new class of vaccines they are developing\u2014will overcome the limitations of current influenza and pneumococcal vaccines used around the world.<\/p>\n<p>Published today in the prestigious journal <i>Nature Microbiology<\/i>, they have shown that the new Influenza A <a href=\"https:\/\/medicalxpress.com\/tags\/virus+vaccine\/\" rel=\"tag\" class=\"\">virus vaccine<\/a> under development (based on inactivated whole influenza virus) induces enhanced cross-protective immunity to different influenza strains, when it is co-administrated with the new class of pneumococcal <a href=\"https:\/\/medicalxpress.com\/tags\/vaccine\/\" rel=\"tag\" class=\"\">vaccine<\/a>.<\/p>\n<p><a href=\"https:\/\/medicalxpress.com\/news\/2019-05-vaccination-approach-killer-diseases.html\" target=\"_blank\" rel=\"noopener noreferrer\"><\/p>\n<div style=\"clear:both;\">Read more<\/div>\n<p><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Scientists from the University of Adelaide\u2019s Research Centre for Infectious Diseases have developed a single vaccination approach to simultaneously combat influenza and pneumococcal infections, the world\u2019s most deadly respiratory diseases. The researchers say a single vaccination\u2014combining vaccines from the new class of vaccines they are developing\u2014will overcome the limitations of current influenza and pneumococcal vaccines [\u2026]<\/p>\n","protected":false},"author":513,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-91035","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/91035","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/513"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=91035"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/91035\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=91035"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=91035"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=91035"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}